Hypereosinophilic Syndrome

This is a condition where your body makes too many white blood cells called eosinophils. These cells normally fight off parasites, but when there are too many, they can cause problems in different parts of your body, like your heart, lungs, or skin. It's a complex condition with various causes.

Condition

What people with Hypereosinophilic Syndrome report

Every report comes from a Lived member, sent anonymously.

Have you tried Prednisone for Hypereosinophilic Syndrome?

NameHow it went

About Hypereosinophilic Syndrome

What It Is

Hypereosinophilic syndrome (HES) is a rare group of disorders in which the blood stays loaded with eosinophils, a type of white blood cell, and those cells damage the body's organs. Eosinophils normally help fight parasites and take part in allergic reactions. In HES, too many of them build up in tissues and release substances that inflame and injure them. Almost any organ can be affected. The skin is involved most often, with itching, rashes, hives or swelling. The lungs, digestive tract, nerves and heart are also common targets, and many people have more than one organ involved. Fatigue, fever, muscle aches and night sweats are frequent general symptoms. Some people have no symptoms at first and learn about the condition from a routine blood count. Heart involvement matters most, because it can lead to blood clots, scarring of the heart's inner lining (sometimes called Loeffler endocarditis) and heart failure.

Causes & Risk Factors

HES is an umbrella term rather than one disease, and the cause shapes everything that follows. In primary or myeloid HES, an acquired change in blood-forming cells in the bone marrow makes them overproduce eosinophils. A well-known example is a gene fusion called FIP1L1-PDGFRA. Some of these forms are classed as a type of blood cancer, chronic eosinophilic leukemia. These gene changes develop during life and are usually not inherited. In secondary or reactive HES, something else drives the eosinophils: a parasitic worm infection, a reaction to a medicine, an inflammatory disease or certain cancers. In the lymphocytic variant, abnormal T cells (another kind of immune cell) release interleukin-5 (IL-5), a signaling protein that tells the body to make eosinophils. A very rare familial form runs in families. When thorough testing finds no cause, the condition is called idiopathic HES, which is common, and some people given that label are later found to have a specific cause. HES can appear at any age but is most often found between about 20 and 50.

How It's Diagnosed

HES is usually suspected when a complete blood count shows a high eosinophil count. A normal count is under about 500 cells per microliter of blood. HES is generally diagnosed when the count is at least 1,500 on more than one occasion, weeks apart (or when a biopsy shows heavy eosinophil buildup in tissue), eosinophils are damaging an organ, and no other condition better explains it. A higher number does not necessarily mean more serious illness: some people with severe organ damage have only modestly raised counts. Much of the workup is a search for the cause, because that decides treatment. Depending on history, this can include stool or blood tests for parasites, a review of medicines, blood chemistry and organ function tests, and imaging of the lungs or abdomen. Every person with suspected HES should have the heart checked with an electrocardiogram (ECG, a tracing of the heart's rhythm) and an echocardiogram (an ultrasound of the heart), with cardiac MRI if those show problems. A bone marrow biopsy, genetic tests for fusions such as FIP1L1-PDGFRA, and specialized blood tests for abnormal T cells help separate the myeloid, lymphocytic and idiopathic forms. Tissue biopsies can confirm that eosinophils are causing damage. Because organ damage can progress, treatment should not wait for every test when the heart or another major organ is already affected.

Treatment Options

Treatment aims to bring the eosinophil count down, stop organ damage from progressing and relieve symptoms. Which approach comes first depends on the type of HES. When a parasite or medicine is responsible, treating the infection or stopping the drug can resolve it. People with familial HES and no symptoms may need only regular monitoring. For myeloid HES with the FIP1L1-PDGFRA fusion or a closely related gene change, the preferred treatment is imatinib, a targeted cancer pill called a tyrosine kinase inhibitor. Most people with these gene changes respond well, though treatment may need to continue long term. Some forms driven by other gene changes do not respond to imatinib and need different, often more intensive treatment. For most other HES, corticosteroids such as prednisone are usually tried first. They often lower eosinophils quickly, and in severe, organ-threatening disease they may be given intravenously in the hospital. The main drawback is that many people need them for a long time, with side effects such as weight gain, high blood sugar, bone thinning and infection risk. Before starting steroids, clinicians consider testing or treating for Strongyloides, a parasitic worm that steroids can turn into a severe, life-threatening infection, particularly in people who have lived in or traveled to areas where it occurs. When steroids alone are not enough or cause too many side effects, other options include hydroxyurea (an oral medicine that slows blood cell production) and interferon alfa, which is often used for the lymphocytic variant. Two injected biologics that block the IL-5 pathway, mepolizumab (Nucala) and benralizumab (Fasenra), are FDA-approved for people 12 and older with HES that is not caused by a non-blood condition such as an infection or drug reaction. In the trial that led to mepolizumab's approval, about half as many people on it had a flare over 32 weeks compared with placebo, and these drugs often let people reduce their steroid dose. Steroids are not stopped abruptly when a biologic starts; any reduction is gradual. People with clots may need blood thinners, and those with severe heart damage occasionally need heart surgery. For aggressive disease that does not respond to other treatment, chemotherapy or a stem cell transplant may be considered.

What to Expect

HES is usually a long-term condition. Many people with the idiopathic form go through periods of control and flares, when symptoms return or eosinophils climb and treatment has to be stepped up. The outlook depends heavily on the type and on which organs are involved, especially the heart. Treatment, including targeted therapy for gene-driven forms and newer biologics, has made long-term control achievable for many people, but there is no single predictable course. Ongoing care usually involves regular blood counts and periodic heart checks such as echocardiograms, even when someone feels well, because organ damage can develop quietly. Much of the day-to-day work is finding the lowest effective treatment, balancing flare control against steroid side effects. Because HES is rare, care is often coordinated by a hematologist or an allergy and immunology specialist, sometimes at a center with experience in eosinophilic disorders, alongside cardiologists or other specialists for the affected organs.

When to Seek Help

Ask for an evaluation if a blood test shows a high eosinophil count that stays raised, especially alongside unexplained fatigue, rash, cough or weight loss. If you have HES, contact your care team promptly about new or worsening shortness of breath (especially when lying down), chest discomfort, palpitations, leg swelling, numbness or tingling in the hands or feet, or symptoms of a flare. Call 911 for signs of a stroke, such as sudden weakness or numbness on one side, trouble speaking or sudden confusion, or for severe chest pain or severe trouble breathing, because HES can cause blood clots and heart damage.

Questions to Ask Your Doctor

  1. 1.Which type of HES do I have, and what tests are still needed to find the cause?
  2. 2.Is my heart or any other organ affected, and how often should it be checked?
  3. 3.Why is this treatment the right first choice for my type of HES, and what will we try if it does not work?
  4. 4.How can we keep my steroid dose as low as possible, and would a biologic like mepolizumab or benralizumab make sense for me?
  5. 5.What should count as a flare, and what should I do when one starts?

Last reviewed • Oct 2026

Educational content, not medical advice.